PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • CSR
  • Investor Relations

About Us

Corporate Overview History Our Culture Leadership

Group Companies

Ascensia Epredia PHCbi Medicom LSI Medience

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

CSR

CORPORATE INTEGRITY

  • Code of Conduct
  • Corporate Governance
  • Risk Management
  • Information Security
  • CSR Procurement
  • Developing Quality Products
  • Customer Satisfaction

PEOPLE INSIGHTS

  • Human Rights Policy
  • Promoting Diversity
  • Work Style Reform
  • Developing Human Resources
  • Creating a Safe & Healthy Workplace

ENVIRONMENTAL SUSTAINABILITY

  • Environmental Activities

SOCIAL RESPONSIBILITY

  • Solving Problems through Business
  • Regional Social Action Programs
  • COVID-19 Response

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Stock Quotations
IR News Financial Highlights IR Calendar Contact IR Disclaimer
NewsroomCareersContact
JP

Other PHC Group Websites

  • PHC Corporation
  • Ascensia Diabetes Care
  • Epredia
  • LSI Medience Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Medicom Corporation
  • PHC Corporation (Shanghai) Ltd.
  • SciMed(Asia)Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • PHC Corporation
  • Ascensia Diabetes Care
  • Epredia
  • LSI Medience Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Medicom Corporation
  • PHC Corporation (Shanghai) Ltd.
  • SciMed(Asia)Pte Ltd
  • Amelieff Corporation
NewsroomCareersContactJP
Newsroom > 2021 > Site Reopening in Response to Lifting of COVID-19 Imposed State of Emergency

News


2021

AnnouncementSeptember 30

Site Reopening in Response to Lifting of COVID-19 Imposed State of Emergency

Our sincere condolences to victims of COVID-19, and we hope for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals on the forefront to treat patients, and everyone helping to support the community infrastructure.

Responding to the Japanese Government’s decision to lift the state of emergency that expires on September 30, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be reopening the following company sites from October 1. However, as we prioritize the safety of customers and employees, employees at the reopening sites will continue to work from home as much as possible. When a customer visit is required, upon receipt of the customer’s consent, the visiting employee will strictly implement infection prevention measures such as temperature measurement, wearing of face masks, hand-washing, etc.

  
PHC Holdings Corporation Shimbashi Headquarters
    Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo
PHC Corporation Shimbashi Headquarters
    Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo

Osaka site
    Address: OAP Tower 16F, 1-8-30 Tenmabashi, Kita-ku, Osaka City, Osaka

Biomedical Business Unit
  ・Hokkaido Sales Office
    Address: Fukuyama Minami-Sanjo Building 6F, 10-1001-5 Minami-Sanjo Nishi, Chuo-ku, Sapporo City, Hokkaido
  ・Tokyo Sales Office/Pharmacy System Sales Office/Delicart Sales Office
    Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo
  ・South Kanto Sales Office
    Address: 1-16-32-106 Fujigaoka, Aoba-ku, Yokohama City, Kanagawa
  ・Chubu Sales Office/Pharmacy System Sales Office/Delicart Sales Office
    Address: Nagoya Panasonic Building 6F, 1-23-30 Izumi, Higashi-ku, Nagoya City, Aichi
  ・Kinki Sales Office/Pharmacy System Sales Office/Delicart Sales Office
    Address: OAP Tower 16F, 1-8-30 Tenmabashi, Kita-ku, Osaka City, Osaka
  ・Chugoku Sales Office
    Address: Kureshin Hiroshima Building 10F, 2-6 Mikawa-cho, Naka-ku, Hiroshima City, Hiroshima
  ・Kyushu Sales Office
    Address: Riverain Center Building 11F, 3-1 Shimokawabata-machi, Hakata-ku, Fukuoka City, Fukuoka

Medical Information Systems Business Unit
  ・Customer Service Department, Field Engagement Promotion Group
    Address: Fukuyama Minami-Sanjo Building 6F, 10-1001-5 Minami-Sanjo Nishi, Chuo-ku, Sapporo City, Hokkaido
  ・Business Transformation Center
    Address: Tokyo Tatemono Shibuya Building 7F, 3-9-9 Shibuya, Shibuya-ku, Tokyo
  ・Omiya Office
    Address: Wellness Cube Omiya 3/4F, 1-853-8 Miyahara-cho, Kita-ku, Saitama City, Saitama
  ・Kyushu Sales Office
    Address: Riverain Center Building 11F, 3-1 Shimokawabata-machi, Hakata-ku, Fukuoka City, Fukuoka

Epredia Anatomical Pathology Business Unit
  ・Shinkoyasu Manufacturing Site
    Address: 3-9 Moriya-cho, Kanagawa-ku, Yokohama City, Kanagawa
  ・CS Repair Warehouse
    Address: 3-22-16 Nishikojiya, Ota-ku, Tokyo

Shonan Health Innovation Park Office
    Address: Shonan Health Innovation Park BW3M-2320, 34-10 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa
PHC Associates CorporationGifu Office
    Address: Lapis Tower 8F, 1-2-3 Yabutaminami, Gifu City, Gifu

The health and safety of our customers, patients, employees and their families are most important to us and we will continue to further strengthen measures to prevent internal and external spread of infection, while working to ensure stable supply for customers and patients who rely on our products and services.

Media contact

Corporate Communications Dept.
PHC Holdings Corporation
+81-3-6778-5311

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.